Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

52results about How to "Excellent drug release performance" patented technology

Water-solubility chitosan microsphere for carrying medicament and preparation thereof

The present invention provides water soluble chitosan microspheres which can be used for loading drug and a preparation method thereof. The structure of the microsphere is that the outside of crosslinking state water soluble chitosan core which can load the drug is orderly enwrapped with a crosslinking state water soluble chitosan coating layer and a crosslinking solidified outer surface layer, which can be used for loading and controlling releasing the drug. The preparation method is that the drug which is mixed with the water soluble chitosan and corresponding water dispersion and oil component are used to form W / O type mixture which is reacted with twain-aldehyde crosslinking agent to obtain microsphere core; water soluble chitosan solution is used to form crosslinking state coating layar at the outer side of the microsphere core; finally, the crosslinking solidified outer surface layer is formed through the second crosslinking reaction. The chitosan microsphere for loading the drug has controllable particle size distribution and slow-release effect, obviously improved intensity and good biological compatibility and biological adhesion, which enlarges the application range for loading drug and has good effect of drug loading, controlling and releasing; the chitosan microsphere for loading the drug can be applied to a plurality of medication forms, such as hypodermic, intravenous and intraperitoneal injection medications, orally taking, etc., the preparation method is simple and feasible with mild condition and low production cost.
Owner:SICHUAN UNIV

Method for preparing quaternary chitosan/imvite nanometer composite material under microwave radiation

The invention provides a method for preparing quaternary chitosan / imvite nanometer composite material under microwave radiation. The method comprises the following steps that: under a condition of microwave radiation, aqueous solution of quaternary chitosan is dripped into imvite suspension; and under the action of shearing force, an interlayer of a quaternary chitosan molecular chain enters the interlayer of the imvite to generate the composite material. In the preparation method under the microwave radiation, the quaternary chitosan / imvite nanometer composite material can be obtained in two hours, which is 12 to 48 times shorter than 24 to 96 hours of the conventional heating method, so that the method improves the reaction efficiency, is 'green' and 'environment-friendly' production technology, and provides feasibility for further industrialization of the quaternary chitosan / imvite nanometer composite material.
Owner:SOUTH CHINA UNIV OF TECH

Drug delivery balloon dilating catheter

ActiveCN103623497ASatisfied with repeated expansionMeet shrinking needsSurgeryDilatorsPorosityBalloon dilatation catheter
The invention provides a drug delivery balloon dilating catheter of a double-layer balloon structure. The drug delivery balloon dilating catheter comprises a pressurizing hole-free inner balloon body and an outer balloon body with a drug-permeable micro-hole permeable membrane. Compared with the prior art, the hole diameter of the drug delivery balloon dilating catheter is even, and the high porosity and the high mechanical strength are achieved. The invention further discloses a manufacturing method of the drug delivery balloon dilating catheter of the double-layer balloon structure, the drug delivery balloon dilating catheter is made of materials such as polyethylene or nylon 12, the micro-hole permeable membrane is manufactured with a thermally induced phase separation method, and the drug delivery balloon dilating catheter has the advantages of being simple in manufacturing process, suitable for large-scale production, low in manufacturing cost and the like.
Owner:SHENZHEN SALUBRIS BIOMEDICAL ENG CO LTD

Polymer conjugate of taxane

[Problems] To provide a novel taxane derivative which can release the medicinal substance in a bioenzyme-independent manner, is expected to have an effective therapeutic efficacy, and has a water-solubility.[Means for Solving Problems] Disclosed is a polymer conjugate of a taxane, which comprises a polymer having a polyethylene glycol moiety and two or more succinic acid monoamide moieties and a taxane, wherein a carboxylate group in the polymer and an alcoholic hydroxyl group in the taxane are bound to each other via an ester bonding.
Owner:NIPPON KAYAKU CO LTD

Nanostructured material formulated with bone cement for effective antibiotic delivery

ActiveUS20120308633A1Preventing postoperative osteomyelitisEnhanced and controlled elutionAntibacterial agentsBiocideFiberCytotoxicity
This invention uses mesoporous silica nanoparticles and other nanostructured materials to formulate polyacrylate-based bone cement for achieving an enhanced and controlled elution of active ingredients such as antibiotics. This invention overcomes the limitation of low antibiotic release from commercial polyacrylate-based bone cements using for example, PMMA. In certain aspects, the formulation enables a sustained release of antibiotics from the bone cement over a period of 80 days and achieves 70% of total drug release, whereas the commercial antibiotic bone cement (e.g., SmartSet GHV) only releases about 5% of the antibiotics on the first day and subsequently an almost negligible amount. In addition, the mechanical properties of our formulated bone cements are well retained. The inventive bone cement exhibits good antibacterial properties and has very low cytotoxicity to mouse fibroblast cells.
Owner:AGENCY FOR SCI TECH & RES

Selenium quantum dot/silicon dioxide/copper sulfide nanocomposite particle, preparation and application thereof

The invention relates to a selenium quantum dot / silicon dioxide / copper sulfide nanocomposite particle, preparation and application thereof. The nanocomposite particle has a chemical formula of Se@SiO2-FA-CuS, selenium quantum dot is adopted as the core, porous silicon dioxide is taken as the shell, amination modification is carried out on the shell surface, and a targeting reagent folic acid is grafted, and then copper sulfide nanoparticles are adsorbed on the shell surface through electrostatic effect. Compared with the prior art, the Se@SiO2-FA-CuS nanocomposite particle provided by the invention has a novel structure and good photothermal performance, has broad application prospects in terms of drug loading, photothermal therapy and targeted transportation, can achieve targeted transportation of anticancer drugs and photothermal reagents to cancer sites, effectively kills cancer cells while reducing the toxic and side effect on normal tissues and cells, further improves the therapeutic effect, and is of enormous potential in promotion of chemotherapy and photothermal therapy (PTT) combined application and enhancement of cancer treatment efficacy.
Owner:SHANGHAI UNIV OF ENG SCI

Hollow hierarchical hydroxyapatite microspheres and preparation method and application thereof

The invention discloses hollow hierarchical hydroxyapatite microspheres and a preparation method and application thereof. The preparation method comprises the following steps of: (1) dissolving diammonium hydrogen phosphate into deionized water, adjusting the pH value of the solution to be 5.8 to 6.0 by using nitric acid, adding calcium nitrate so that the molar ratio of Ca<2+> to PO4<3-> in the solution is 1.6 to 1.7, continuously adjusting the pH value of the solution to be 5.0 by using the nitric acid, adding sodium citrate into the mixed solution to ensure that the concentration of the mixed solution is 9 to 20 milligrams per milliliter, and continuously stirring; and (2) transferring the mixed solution of the step (1) to a high pressure reactor, wherein the volume of the mixed solution accounts for 50 to 80 percent of the total volume of the reactor; and reacting for 1 to 12 hours at the temperature of between 80 and 220 DEG C, performing natural cooling, washing for 3 to 5 times, and drying to obtain the hollow hierarchical hydroxyapatite microspheres. The preparation method for the microspheres is simple and low in time consumption; and the microspheres have excellent medicament release property, are suitable for industrial production, and have a good application prospect.
Owner:广州康睿医疗器械有限公司

Medical dressing with drug loading function and preparation method thereof

The invention discloses a preparation method of a medical dressing with a drug loading function. The method includes the following steps that firstly, an electrospinning solution containing drug is prepared; secondly, electrostatic spinning is conducted; thirdly, a prepared product is subjected to drug controlled release testing. The prepared composite medical dressing containing antibacterial drug / PVA / oxidized graphene is excellent in processing performance. The prepared product has excellent drug controlled release capacity. The method is simple in process, low in cost and easy to use and popularize widely in the medical material field.
Owner:JINLING INST OF TECH

Low-polylactic acid-beta-cyclodextrin and polylactic acid blended nano-fiber prepared by electrospinning

The invention relates to a method for manufacturing a low-polylactic acid-beta-cyclodextrin and polylactic acid blended nano-fiber. The method includes dissolving low-polylactic acid-beta-cyclodextrin and polylactic acid in methylene chloride and N,N-dimethylformamide (DMF), stirring the mixture until the low-polylactic acid-beta-cyclodextrin and the polylactic acid are completely dissolved, and performing standing ultrasonic treatment for the solution to obtain transparent low-polylactic acid-beta-cyclodextrin and polylactic acid solution; and adding the low-polylactic acid-beta-cyclodextrin and polylactic acid blended solution in an injection pump, adjusting electrospinning voltage to range from 15kV to 28kV, setting the distance from a spinning nozzle to a collecting plate to range from 15cm to 25cm and solution flow rate to range from 1.0mL / h to 2.0mL / h, using a collector as an aluminum foil and carrying out high-voltage electrospinning to obtain the low-polylactic acid-beta-cyclodextrin and polylactic acid blended nano-fiber. The prepared functional nano-fiber has excellent biocompatibility and biodegradability and accordingly has a high application value in drug controlled release systems.
Owner:HANGZHOU INST OF ADVANCED MATERIAL BEIJING UNIV OF CHEM TECH

Chitosan/starch blending medicine-carrying fibre, preparation method and use thereof

The medicated chitosan / starch fiber with excellent mechanical performance is prepared with the mixture comprising starch 10-65 wt%, salicylic acid 5-15 wt% and chitosan 30-85 wt%, and has stretch rate of 10-30 %. It is prepared through dissolving chitosan in acetic acid solution to obtain 3-5 wt% concentration chitosan solution, dissolving starch in distilled water to obtain 3-5 wt% concentration starch solution, mixing the chitosan solution, the starch solution and salicylic acid in the weight ratio, filtering, debubbling, adding solidifying solution and solution spinning at room temperature. The medicated chitosan / starch fiber may be applied widely in medicine and other field, and is especially suitable for producing non-woven fabric acting as wound dressing.
Owner:华山科技股份有限公司

Nano-lipid carrier for embedding vitamin A alcohol and preparation method thereof

The invention discloses a nano-lipid carrier for embedding vitamin A alcohol and a preparation method of the nano-lipid carrier for embedding the vitamin A alcohol, relates to the field of skin-care products, and solves the problems of high irritation and poor stability caused by directly applying the vitamin A alcohol to the skin-care products. The nano-lipid carrier for embedding the vitamin A alcohol comprises the following components in weight by percentage: 8 to 12% of Hawaiian soybean oil, 8 to 12% of palm wax, 1 to 5% of vitamin A alcohol, 8 to 12% of a nonionic surfactant, 1 to 3% of an alcohol solvent, 0.1 to 1% of phospholipid and the balance of water. According to the invention, the raw materials of the Hawaiian soybean oil, the palm wax, the surfactant and the like are mutuallymatched for embedding the vitamin A alcohol, the nano-lipid carrier for embedding the vitamin A alcohol is applied to the skin-care products, so that the skin-care products have the advantages of lowirritation, good drug release and the like and oxidation of the vitamin A alcohol is avoided; an embedding system in the invention can well embed the vitamin A alcohol, and the embedding rate is close to 100%; the interface potential value of the nano-lipid carrier is between minus 33mV to minus 49mV, and the nano-lipid carrier further has good stability and dispersion.
Owner:上海格兰化妆品有限公司

PVP-modified sodium alginate/polydopamine composite nano-material and preparation and application thereof

The invention provides a preparation method of a PVP-modified sodium alginate / polydopamine composite nano-material. The preparation method is characterized by comprising the following steps: sprayingan aqueous solution containing sodium alginate and dopamine to a coagulating bath with pH 9-11 and containing polyvinylpyrrolidone (PVP), CaCl2 and trihydroxymethyl aminomethane, centrifuging and separating, and washing to obtain the PVP-modified sodium alginate / polydopamine composite nano-material. In vitro / in vivo biosecurity experiments and cancer therapy experiments prove that the PVP-modifiedsodium alginate / polydopamine composite nano-material has excellent biocompatibility, phototherapeutic ability and photothermal therapy and chemotherapy combined treatment ability.
Owner:UNIV OF SHANGHAI FOR SCI & TECH

Closed hydrogel as well as preparation method and application thereof

The invention belongs to the technical field of high polymer materials, and particularly relates to closed hydrogel as well as a preparation method and application thereof. Raw materials for preparingthe closed hydrogel comprise a first component and a second component, wherein the first component comprises a compound A and a compound B; the compound A is a derivative of multi-arm polyethylene glycol, and the compound B is multi-arm copolyester of glycidyl isopropyl ether and ethyl glycidyl ether; and the second component comprises oligopeptide or a derivative thereof. According to the hydrogel, the swelling rate of the hydrogel can be effectively reduced by selecting high molecular weight compounds in the gel components and matching the first component with the second component.
Owner:NKD PHARMA CO LTD

Sericin hydrogel as well as preparation method and application thereof

The invention discloses sericin hydrogel and a preparation method thereof. The sericin hydrogel is prepared by reaction of a sericin aqueous solution and a cross-linking agent aqueous solution. The preparation method comprises the following steps: cleaning, drying and crushing silkworm cocoons without silk fibroin to obtain a silkworm cocoon powder, adding water, performing reaction at 100-180 DEG C for 0.5-10 hours, performing centrifuging to remove insoluble substances, and collecting a clarified solution to obtain a sericin aqueous solution with the concentration of 2-18%; and preparing a cross-linking agent aqueous solution, filtering and degerming by a filter membrane, adding sterilized material into the sericin aqueous solution, performing uniform mixing, and performing oscillating in a shaking table for 20-120 minutes. The sericin hydrogel has excellent mechanical property, porous microstructure, deformation memory property and sterility, can be used as a carrier of a drug or a growth factor, and is freeze-dried to obtain a sericin biological scaffold, and the scaffold can be applied to repair of tissue damage and treatment of diseases. The preparation method is simple, the gelling process is controllable, and the gelling time can be regulated and controlled by regulating the concentration of sericin.
Owner:JIANGSU UNIV OF SCI & TECH

Reducibly degradable amphiphilic block copolymer and preparation and application of amphiphilic block copolymer used as drug carrier

The invention provides a preparation method of a reducibly degradable amphiphilic block copolymer used as a drug carrier, and belongs to the technical field of macromolecular chemical and biological medicines. The method comprises a step of bonding rhodamine B serving as a fluorescent agent to a disulfide bond monomer through esterification, and bonding to N-(2-hydroxypropyl) methacrylamide in a RAFT mode to form the amphiphilic block copolymer with high biocompatibility. According to the amphiphilic block copolymer, a nano-micelle drug carrier can be formed in a mixed solution of methanol and water. In a reducing environment, the disulfide bond in a hydrophobic chain segment of the amphiphilic block copolymer can be reduced into a sulfydryl group, and the grafted rhodamine B group is removed out of the side chain of the polymer to result in reduction of the grain size of micelle and obvious change of the structural properties of the drug carrier, so that the amphiphilic block copolymer shows high reducibility, degradability and drug release property; therefore, the amphiphilic block copolymer can be used as the drug carrier to be applied to preparation of medicines.
Owner:NORTHWEST NORMAL UNIVERSITY

Bioadhesive temperature-sensitive material, preparation method thereof and application of drug carrier

The invention discloses a bioadhesive temperature-sensitive material, a preparation method thereof and application of a drug carrier. The material does not need to be additionally provided with a cross-linking agent or subjected to other treatment, an aqueous solution of the material is dehydrated and gelled by polyoxyethylene-polyoxypropylene-polyoxyethylene chains along with temperature rise, the material has good temperature sensitivity, and meanwhile, catechol terminal groups of the material can be spontaneously and chemically cross-linked with one another or can be spontaneously and chemically cross-linked with amino on the surface of a living body to generate super-strong bioadhesive force. The bioadhesive temperature-sensitive material is combined with a temperature-sensitive gel matrix and a stabilizer and can be used as a delivery carrier of bioactive factors. Bioadhesive temperature-sensitive drug-loaded hydrogel can be directly used for perfusion and administration in a cavity, can quickly respond to body temperature change for gelling, meanwhile can be uniformly adhered to the surface of mucosa of the cavity, slowly releases the bioactive factors and promotes repair ofthe ulcerative mucosa.
Owner:WENZHOU MEDICAL UNIV

Graphene oxide-hydrogel composite drug carrier

The invention discloses a graphene oxide-hydrogel composite drug carrier. The graphene oxide-hydrogel composite drug carrier is prepared by polymerization of water-soluble graphene oxide, hydroxyethyl methylacrylate and N-vinyl pyrrolidone in water in the presence of a redox initiator, wherein the water-soluble graphene oxide is a graphene oxide-segmented polyether F-127 mixed aqueous solution. The graphene oxide-hydrogel composite drug carrier has good biocompatibility, good processability, good drug controlled-release capability, performances satisfying drug carrier basic-requirements, and large social and economic benefits, and can control drug release.
Owner:西安萱御紫金药业有限公司

Surface coating composition of implantable medical apparatus, medical apparatus and manufacturing method of medical apparatus

The invention provides a surface coating composition of an implantable medical apparatus, the medical apparatus and a manufacturing method of the medical apparatus, wherein the surface coating composition is at least prepared by mixing a degradable carrier and therapeutic drugs; the degradable carrier is selected from either polylactic acid or a copolymer thereof; and the weight of the therapeutic drugs accounts for 0.1-80% in terms of the weight of the surface coating. The coating provided by the invention has such outstanding performances that the coating is excellent in drug controlled-release property, good in binding property with a main body stent, uniform in degradation and the like, and a degradation product is harmless to human body. Meanwhile, a provided coating preparation technique has significant advantages of being simple and convenient to operate, high in yield, being controllable and the like.
Owner:NANJING YONGMING MEDICAL APP & INSTR CO LTD

Sulfydryl-containing zwitterionic polypeptide modified doxorubicin derivative, nano-micelle and preparation methods of doxorubicin derivative and nano-micelle

The invention provides a sulfydryl-containing zwitterionic polypeptide modified doxorubicin derivative, a nano-micelle and a preparation method of the nano-micelle, and belongs to the field of biological medicines. The doxorubicin derivative has a structure as shown in a general formula (I). The preparation method of the doxorubicin derivative comprises the following steps of in a polar solvent, mixing sulfydryl-containing zwitterionic polypeptide with acryloylhydrazine to react, and performing crystallizing to obtain a polypeptide derivative; and dissolving the polypeptide derivative and doxorubicin hydrochloride in the polar solvent according to a molar ratio of 1: (0.2-5), adding a trifluoroacetic acid catalyst, and carrying out a stirring reaction to obtain the doxorubicin derivative.The nano-micelle prepared from the doxorubicin derivative is long in in-vivo blood circulation time, high in drug loading capacity, small in toxic and side effects, good in pH value response and goodin tumor inhibition effect.
Owner:YANSHAN UNIV

Drug controlled-release mesoporous silicon nanoparticles and preparation method thereof

The invention discloses drug controlled-release mesoporous silicon nanoparticles and a preparation method thereof. The preparation method comprises the following steps: (1) adding 3-aminopropyltriethoxysilane into mesoporous silicon nanoparticles, carrying out a reflux reaction under the protection of nitrogen by taking toluene as a solvent, washing with ultrapure water and ethanol after the reaction is finished, and carrying out vacuum drying to obtain aminated mesoporous silicon nanoparticles MSN-NH2; (2) dissolving the aminated mesoporous silicon nanoparticles in acetonitrile, adding 1-pyreneformaldehyde for a reaction, centrifuging after the reaction is finished, washing with ultrapure water and ethanol, and performing vacuum drying to obtain MSN-N = CH-Py; and (3) taking MSN-N = CH-Py, adding a to-be-loaded drug solution to react, adding beta-cyclodextrin to continue to react after the reaction is finished, centrifuging after the reaction is finished, washing with ultrapure waterand ethanol, and carrying out vacuum drying to obtain the product. The drug controlled-release mesoporous silicon nanoparticles disclosed by the invention have good responsiveness to pH, and have gooddrug loading capacity and drug controlled-release performance.
Owner:HUNAN PROVINCIAL TUMOR HOSPITAL

Medical cold compress patch and preparation method

A medical cold compress patch includes a backing layer, a gel layer and a covering layer. The gel layer includes various raw materials, and each raw material is measured as following mass percentage, 2 to 15 mass percent of macromolecule substance, 2 to 10 mass percent of epidermal growth factor, 2 to 8 mass percent of ceramide, 3 to 8 mass percent of humectant, 3 to 10 mass percent of bupleurum sinensis extract, 2 to 8 mass percent of dandelion extract, 3 to 12 mass percent of cortex phellodendri extract, 5 to 10 mass percent of aloe vera extract, 2 to 10 mass percent of honeysuckle flowers extract and the balance being purified water. A method for preparing medical cold compress patch is also disclosed.
Owner:SHANDONG ZHUSHI PHARMA GRP CO LTD

Water-soluble chitosan microsphere for carrying medicament and preparation thereof

Water-soluble chitosan microspheres that can be used to load drugs and a preparation method thereof. The structure of the microsphere is that the cross-linked water-soluble chitosan core that can be loaded with drugs is sequentially wrapped with a cross-linked water-soluble chitosan coating layer and a cross-linked cured outer layer, which can be used for drug loading and control. freed. The preparation method is to first form a W / O mixture of water-soluble chitosan and corresponding water-dispersed drugs and oily ingredients, react with dialdehyde cross-linking agents to obtain drug-loaded microsphere cores, and then water-soluble shells The polysaccharide solution forms a cross-linked covering layer on its outside, and finally forms a cross-linked solidified surface layer through a second cross-linking reaction. The particle size distribution and sustained release effect of the chitosan drug-loaded microspheres are controllable, the strength is significantly improved, the biocompatibility and bioadhesion are good, the application range of drug loading is expanded, and the drug entrapment and controlled release effects are good. It can be used in multiple administration methods such as subcutaneous, intravenous and intraperitoneal injection, oral administration, etc., and the preparation method is simple and easy, the conditions are mild, and the production cost is low.
Owner:SICHUAN UNIV

Preparation method and application of graphene oxide modified carboxymethyl chitosan composite hydrogel

The invention discloses a preparation method and application of graphene oxide modified carboxymethyl chitosan composite hydrogel, an ionic cross-linking method is adopted, a graphene oxide dispersion solution is added into a carboxymethyl chitosan solution according to a proportion, uniform mixing is performed, triphosphoric acid is added, gelatin is added to enhance water solubility and biocompatibility, and the graphene oxide modified carboxymethyl chitosan composite hydrogel is prepared. According to the present invention, the prepared composite hydrogel material has characteristics of large specific surface area, good swelling property, good thermal stability, good biocompatibility and good pH sensitive property, can be used as the sustained-release material, can improve the adhesion site of the drug, can improve the drug loading capacity, has good drug controlled-release performance, and can be used in the field of drug delivery. The medicine release time can be prolonged, the medicine curative effect is improved, the administration frequency is reduced, the precise controlled release efficiency of the medicine is improved, and the in-vitro release of the medicine is favorably controlled.
Owner:广东省科学院生物与医学工程研究所

Magnetic nano-drug carrier as well as preparation method and application thereof

The invention relates to the technical field of drug carriers, in particular to a magnetic nano-drug carrier as well as a preparation method and an application thereof. The magnetic nano-drug carrier comprises an SP94 targeting peptide and a coupling product of an siRNA delivery carrier, and the coupling product of the siRNA delivery carrier comprises superparamagnetic iron oxide nanoparticles and quaternary ammonium cationized amylose-tetraphenylethylene-superparamagnetic iron oxide nanoparticles formed by coupling quaternary ammonium cationized amylose and tetraphenylethylene, and the siRNA is adsorbed in the magnetic nano-drug carrier. The cytotoxicity experiments prove that the nano-drug carrier has good biocompatibility, good stability, targeting property and drug release property, and the magnetic nano-drug carrier can be applied to preparation of cancer gene therapy drugs.
Owner:SUN YAT SEN MEMORIAL HOSPITAL SUN YAT SEN UNIV

Soluble self-healing natural polymer hydrogel and preparation method thereof

The invention discloses a soluble self-healing natural polymer hydrogel and a preparation method thereof. Natural polymer sodium alginate can be used as raw material, functional monomer methacrylic acid can be introduced, initiator and deionized water can be used as auxiliary raw material, and thus the natural polymer hydrogel (SAM) with excellent self-healing and solubility can be prepared by one-pot method. The hydrogel prepared by the invention has the advantages of fast self-healing rate, healing with no limitation of incision section and good solubility. The hydrogel is put into a certainamount of water, and the hydrogel can be completely dissolved without residue. The hydrogel is used as a drug carrier, and the drug release rate is stable, and the 100% of drug can be completely released without residue. And the prepared hydrogel has good biocompatibility and degradability, and the soluble self-healing natural polymer hydrogel prepared by the invention has wide application prospects in the fields of biomedical materials such as wound dressing, tissue organ culture and biological scaffold materials.
Owner:EAST CHINA NORMAL UNIV

A kind of nano-lipid carrier embedding vitamin A alcohol and preparation method thereof

The invention discloses a nano-lipid carrier for embedding vitamin A alcohol and a preparation method of the nano-lipid carrier for embedding the vitamin A alcohol, relates to the field of skin-care products, and solves the problems of high irritation and poor stability caused by directly applying the vitamin A alcohol to the skin-care products. The nano-lipid carrier for embedding the vitamin A alcohol comprises the following components in weight by percentage: 8 to 12% of Hawaiian soybean oil, 8 to 12% of palm wax, 1 to 5% of vitamin A alcohol, 8 to 12% of a nonionic surfactant, 1 to 3% of an alcohol solvent, 0.1 to 1% of phospholipid and the balance of water. According to the invention, the raw materials of the Hawaiian soybean oil, the palm wax, the surfactant and the like are mutuallymatched for embedding the vitamin A alcohol, the nano-lipid carrier for embedding the vitamin A alcohol is applied to the skin-care products, so that the skin-care products have the advantages of lowirritation, good drug release and the like and oxidation of the vitamin A alcohol is avoided; an embedding system in the invention can well embed the vitamin A alcohol, and the embedding rate is close to 100%; the interface potential value of the nano-lipid carrier is between minus 33mV to minus 49mV, and the nano-lipid carrier further has good stability and dispersion.
Owner:上海格兰化妆品有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products